Hua Medicine

Hua Medicine is a clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. The company has in-licensed from major pharma, world-wide rights to a potential best-in-class, oral drug for the treatment of Type 2 Diabetes which utilizes a novel mechanism of action.
Company Growth (employees)
Type
Private
HQ
Shanghai, CN
Founded
2010
Size (employees)
18 (est)+6%
Hua Medicine was founded in 2010 and is headquartered in Shanghai, CN

Key People at Hua Medicine

Li Chen

Li Chen

President and CEO

Hua Medicine Office Locations

Hua Medicine has an office in Shanghai

Hua Medicine Data and Metrics

Summary Metrics

Founding Date

2010

Total Funding

$125 m

Latest funding size

$50 m

Time since last funding

over 1 year

Investors

Hua Medicine's latest funding round in April 2016 was reported to be $50 m. In total, Hua Medicine has raised $125 m

Hua Medicine Job Categories

Traffic Overview of Hua Medicine

Hua Medicine Company Life and Culture

You may also be interested in